How GLP-1 medications support weight management

GLP-1 stands for glucagon-like peptide-1, a hormone your gut releases after you eat. It helps the body sense fullness, slows how quickly food leaves the stomach, and plays a role in blood-sugar signaling. GLP-1 receptor agonists are prescription medicines designed to act on that same pathway.

By supporting appetite and fullness signals, these medicines can help people feel satisfied sooner and stay full longer as part of a broader weight-management plan. They work through biology—not willpower alone—and they are one tool a licensed provider may consider after reviewing your health history and goals.

Two options often discussed in medical weight programs are semaglutide and tirzepatide. Semaglutide acts on the GLP-1 receptor. Tirzepatide acts on receptors for both GLP-1 and another gut hormone, GIP. Which medicine, if either, fits a given person is a clinical decision—not something this article can settle.

Semaglutide and tirzepatide require medical evaluation and ongoing provider oversight. A licensed provider reviews your history, may order lab work, and decides whether any medication belongs in your plan. That supervision is part of how these therapies are offered on our platform.

Medication works best next to nutrition and activity changes, not in place of them. Sustainable habits—how you eat, move, sleep, and manage stress—still shape how any supervised program feels day to day. Results differ from person to person, and nothing here promises a specific outcome.

If you want to go deeper, browse the semaglutide and tirzepatide pages in our therapy library for plain-language education on what each supports. Our shop shows current availability and pricing, and a licensed provider determines eligibility and next steps when evaluation is required.